NDC 51662-1587

XYLOCAIN (LIDOCAINE HCl )

Xylocaine (lidocaine Hcl )

XYLOCAIN (LIDOCAINE HCl ) is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride Anhydrous.

Product ID51662-1587_e1838a93-7f2b-14f1-e053-2a95a90a8d69
NDC51662-1587
Product TypeHuman Prescription Drug
Proprietary NameXYLOCAIN (LIDOCAINE HCl )
Generic NameXylocaine (lidocaine Hcl )
Dosage FormInjection, Solution
Route of AdministrationINFILTRATION; PERINEURAL
Marketing Start Date2022-06-15
Marketing CategoryNDA /
Application NumberNDA006488
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameLIDOCAINE HYDROCHLORIDE ANHYDROUS
Active Ingredient Strength10 mg/mL
Pharm ClassesAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51662-1587-3

25 POUCH in 1 CASE (51662-1587-3) > 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1587-2) > 50 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2022-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.